Awards & Advancement

Clintrax Global adds Bradford Evans as vice president of administration

Thursday, August 21, 2014 10:14 AM

Clintrax Global, a worldwide provider of clinical research services located in Raleigh, N.C., recently announced the addition of Bradford Evans as vice president of administration. Evans will oversee all corporate processes, including their alignment with company objectives and policies.

More... »

WIRB Copernicus Group

MediciGlobal appoints Linda Capsey vice president

Thursday, August 21, 2014 10:07 AM

MediciGlobal, a global provider of patient recruitment and retention for clinical trials with offices in Pennsylvania and London, has appointed Linda Capsey, Ph.D., vice president project management and innovation. Capsey will provide strategic and operational oversight for recruitment-retention program development, site training workshops for patient communications and informed consent, and work as a consultant to biopharmaceutical companies for patient recruitment-retention planning and feasibility.

More... »


Bedrocan Cannabis appoints three as independent directors

Thursday, August 21, 2014 09:58 AM

Bedrocan Cannabis, previously Bedrocan Canada has appointed three independent members to its board of directors, enhancing executive oversight and strengthening the health care experience of the company, a licensed researcher and producer of medicinal cannabis in Canada.

More... »

Telik appoints new board of director members

Friday, August 15, 2014 12:19 PM

Telik, a clinical stage oncology drug development company based in California, which recently merged with MabVax Therapeutics in July, has appointed six new members of the board of directors to help guide the company and its management in developing an expanded product development pipeline post-merger.

More... »

Peter Hirth joins Trovagene's scientific advisory board

Friday, August 15, 2014 10:34 AM

Trovagene, a California-based developer of cell-free molecular diagnostics, has hired K. Peter Hirth, Ph.D., who joins the company's scientific advisory board. A pioneer in the field of personalized medicine, Hirth led the organizations that developed both Sutent and Zelboraf; two successful targeted cancer therapeutics.

More... »

Susan Dallabrida named to PharmaVOICE 100

Friday, August 15, 2014 09:25 AM

PHT has announced Susan Dallabrida, Ph.D., vice president of clinical science and consulting, is among this year’s PharmaVOICE 100 most inspiring professionals in the life sciences industries. Dallabrida is the 6th PHT executive to earn a place on the list. PHT is a provider of technologies used to collect patient-driven eData for clinical research.

More... »

Theravance appoints Michael W. Aguiar as president, CEO

Friday, August 8, 2014 12:29 PM

Theravance has appointed Michael W. Aguiar as president and CEO effective August 15, and as a member of the board of directors effective immediately. Aguiar plans to continue to as Theravance's senior vice president and chief financial officer until his replacement is identified and appointed. 

More... »

HeartWare International appoints Katrin Leadley chief medical officer

Monday, August 4, 2014 03:48 PM

HeartWare International, an innovator of less invasive, miniaturized circulatory support technologies for advanced heart failure, has appointed Katrin Leadley, M.D., as chief medical officer of HeartWare, effective September 1. Leadley brings to HeartWare extensive strategic leadership, with more than 20 years of clinical and industry experience at life sciences firms, including QuintilesBoston Scientific and JenaValve Technology in Munich, where she spent the last three years as chief medical officer leading the company's clinical, regulatory, scientific and medical activities.

More... »

ibidi awarded with seal of quality

Monday, August 4, 2014 03:44 PM

The German Stifterverband, an association that promotes science and education in Germany, has awarded ibidi with their seal of quality for the company's ongoing and focused commitment to research and development.

More... »

INC Research appoints Jan Schreur senior vice president, human resources

Thursday, July 31, 2014 01:22 PM

INC Research, a global phase I to IV CRO, has appointed Jan Schreur as the company's senior vice president, human resources. Schreur brings nearly 30 years of progressive human resources experience to the role, including senior leadership positions at global biopharmaceutical organizations.

More... »

Subscribe to The CenterWatch Monthly
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

August 18

Ebola outbreak highlights need to improve biosafety, infrastructure to handle future health emergencies

More African American professional women open to participating in medical research

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

August

Reality of costs and impact rain on Sunshine Act
Concerns mount over compliance burden on CROs, sponsors, unanticipated consequences for research

Cloud computing expanding into all areas of clinical trial conduct
Benefits outweigh the complexities, challenges of finding right vendors

Already a subscriber?
Log in to your digital subscription.

Purchase the August issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

July

IRB market consolidating rapidly
Private equity driving a new commercial ethical review landscape

Lessons learned from medical device trials
Smaller, faster, more flexible trials hold important insights for pharmaceutical innovation

Already a subscriber?
Log in to your digital subscription.

Purchase the July issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs